Buy these top quality ASX 200 shares for your self-managed superannuation fund

Analysts think these are top buys for super investors right now.

| More on:
Couple holding a piggy bank, symbolising superannuation.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for some ASX 200 shares for your self-managed superannuation fund (SMSF) this month?

If you are, it could be worth checking out the quality companies named below. They have all been tipped as buys with attractive upside. Here's what you need to know about them:

CSL Limited (ASX: CSL)

CSL could be a great option for a SMSF. It is one of the world's leading biotechnology companies that has been around for over a century, starting life as the Commonwealth Serum Laboratories.

It has stayed true to its roots since then with its key CSL Behring plasma business, whilst also expanding into other areas through its CSL Seqirus vaccines business and the CSL Vifor renal therapies business.

But CSL won't be stopping there. Each year it reinvests 10% to 12% of its sales back into research and development (R&D) activities. This ensures that it stays at the forefront of the industry and has a pipeline of potentially lucrative products to underpin its long term growth.

Analysts at Citi are positive on the company. They currently have a buy rating and $335.00 price target on its shares. Based on the current CSL share price, this implies potential upside of 10%.

Goodman Group (ASX: GMG)

Another ASX 200 share for SMSF investors to consider is Goodman Group. It is a leading integrated commercial and industrial property company.

It has been among the best performers on the Australian share market over the past decade. This has been driven by the insatiable demand for industrial property and management's strategy of developing high-quality properties in strategic locations.

Goodman appears well-placed to continue this positive form for the foreseeable future. This is thanks to its huge development pipeline, which includes data centres that are in demand due to the artificial intelligence megatrend.

Citi is also bullish on Goodman and has a buy rating and $40.00 price target on its shares. Based on its current share price of $34.58, this implies potential upside of almost 16%.

ResMed Inc. (ASX: RMD)

A third ASX 200 share to look at for your SMSF could be ResMed. It is a leading medical device company with a focus on the sleep disorder market.

This is a huge market to operate in. For example, last week its CEO, Mick Farrell stated that "nearly 2.5 billion suffer from major sleep health and breathing disorders."

And "as the market leader in these significantly underpenetrated markets, we're well-positioned as the clear leader to drive increased market penetration, demand generation, and accelerate growth for our businesses," Farrell added.

It's no wonder then that a number of brokers are bullish on ResMed. One of those is Macquarie, which has an outperform rating and $35.40 price target on its shares. This suggests that upside of over 11% is possible from current levels.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in CSL and ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goodman Group, Macquarie Group, and ResMed. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended CSL and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Person holding a blue chip.
Blue Chip Shares

Why 14 analysts are bullish on this ASX blue-chip share

Experts are widely bullish on the prospects of this stock.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Blue Chip Shares

2 strong ASX blue-chip shares rated as buys by this top fund manager

These businesses have a lot going for them.

Read more »

A group of people in suits watch as a man puts his hand up to take the opportunity.
Blue Chip Shares

2 of the best ASX 200 blue chip shares to buy in August

Let's see which blue chips Bell Potter is bullish on.

Read more »

Person holding a blue chip.
Blue Chip Shares

4 ASX 200 blue-chip shares to hold but not buy: experts

These blue-chips are worth holding if you already own them, but are too expensive for new investors to buy.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Blue Chip Shares

2 strong blue chip ASX 200 shares to buy with $20,000

Let's see why analysts think these top stocks could be buys.

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Blue Chip Shares

Should you buy, hold, or sell CBA, Fortescue, and Woolworths shares?

One broker has given its verdict on these blue chips.

Read more »

Happy man working on his laptop.
Blue Chip Shares

3 ASX blue chips to buy before earnings season

Analysts recently named these shares as buys. Let's see what they are recommending.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Blue Chip Shares

2 of the best ASX 200 blue chip shares to buy now

Bell Potter sees these as the creme de la creme right now.

Read more »